RSRichard Sloane

Richard Sloane

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Richard Sloane has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Causality Patterns for Detecting Adverse Drug Reactions From Social Media: Text Mining Approach

    by Danushka Bollegala, Simon Maskell, Richard Sloane, Joanna Hajne, Munir Pirmohamed

    A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.


  • Open Access

    Causality Patterns for Detecting Adverse Drug Reactions From Social Media: Text Mining Approach (Preprint)

    by Danushka Bollegala, Simon Maskell, Richard Sloane, Joanna Hajne, Munir Pirmohamed

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Detecting adverse drug reactions (ADRs) is an important task that has direct implications for the use of that drug. If we can detect previously unknown ADRs as quickly as possible, then this information can be provided to the regulators, pharmaceutical companies, and health care organizations, thereby potentially reducing drug-related morbidity and saving lives of many patients. A promising approach for detecting ADRs is to use social media platforms such as Twitter and Facebook. A high level of correlation between a drug name and an event may be an indication of a potential adverse reaction associated with that drug. Although numerous association measures have been proposed by the signal detection community for identifying ADRs, these measures are limited in that they detect correlations but often ignore causality. Objective: This study aimed to propose a causality measure that can detect an adverse reaction that is caused by a drug rather than merely being a correlated signal. Methods: To the best of our knowledge, this was the first causality-sensitive approach for detecting ADRs from social media. Specifically, the relationship between a drug and an event was represented using a set of automatically extracted lexical patterns. We then learned the weights for the extracted lexical patterns that indicate their reliability for expressing an adverse reaction of a given drug. Results: Our proposed method obtains an ADR detection accuracy of 74% on a large-scale manually annotated dataset of tweets, covering a standard set of drugs and adverse reactions. Conclusions: By using lexical patterns, we can accurately detect the causality between drugs and adverse reaction–related events.


  • Social media and pharmacovigilance: A review of the opportunities and challenges

    by Richard Sloane, Orod Osanlou, David Lewis, Danushka Bollegala, Simon Maskell, Munir Pirmohamed

    Adverse drug reactions come at a considerable cost on society. Social media are a potentially invaluable reservoir of information for pharmacovigilance, yet their true value remains to be fully understood. In order to realize the benefits social media holds, a number of technical, regulatory and ethical challenges remain to be addressed. We outline these key challenges identifying relevant current research and present possible solutions.


  • Open Access

    The Physics of the B Factories

    by A. J. Bevan, B. Golob, Th. Mannel, S. Prell, B. D. Yabsley, H. Aihara, F. Anulli, N. Arnaud, T. Aushev, M. Beneke, et al.


  • Open Access

    The BB detector: Upgrades, operation and performance

    by B. Aubert, R. Barate, D. Boutigny, F. Couderc, P. del Amo Sanchez, J.-M. Gaillard, A. Hicheur, Y. Karyotakis, J.P. Lees, V. Poireau, et al.


  • Abstract CN09-03: Capitalizing on the teachable moment of the cancer diagnosis to promote healthful lifestyle changes among women with breast cancer and their daughters: Preliminary findings of the DAMES Trial

    by Wendy Demark-Wahnefried, Lee W. Jones, Denise C. Snyder, Gretchen Kimmick, Bercedis L. Peterson, Richard Sloane, Hoda Badr, Stephanie Barrera, Mary Katherine Bispeck, Daniel Hughes, et al.

    Introduction: Excessive body weight, as reflected by a body mass index [BMI (kg/m2) > 25] is consistently and independently associated, not only with post‐menopausal breast cancer incidence, but mortality as well, with weight gain during adulthood being most strongly associated with risk. In addition, there is consensus that an increased BMI at the time of diagnosis is a poor prognostic indicator, and accumulating evidence that weight gain post‐diagnosis is associated with poorer overall and disease‐free survival. Thus, to reduce the burden of breast cancer, efforts are needed to promote weight control and to target those most at risk, i.e., women who already have breast cancer (for tertiary prevention of progressive/ recurrent disease and co‐morbidity) and their 1st degree relatives (as a means of primary prevention). Previous studies also suggest that the cancer diagnosis catalyzes a “teachable moment” that may provide an opportune time for health promotion. The DAMES trial (Daughters And MothErS against breast cancer) is currently in the field and will explore whether the momentum of the teachable moment created by the cancer diagnosis, as well as the mother‐daughter bond, can be harnessed and used to promote weight loss in overweight women with breast cancer and their overweight adult daughters, and to discern whether team‐based vs. independently‐delivered interventions offer more promise. Methods: 68 women diagnosed with loco‐regional breast cancer within 5‐years and their adult daughters (body mass index [BMI] 25+) were randomized to: 1) a tailored diet‐exercise intervention emphasizing the mother‐daughter team (TEAM); 2) a tailored diet‐exercise intervention delivered to mothers and daughters independently (INDEPENDENT); or 3) an attention control arm that received standardized diet‐exercise materials in the public domain (CONTROL); the unit of randomization was the motherdaughter dyad and the distribution of dyads was as follows: 25 dyads in the TEAM; 25 dyads in the INDEPENDENT, and 18 dyads in the CONTROL arms. All interventions consisted of mailed print materials (personalized workbook, plus 6 mailings over the course of the 1‐year study period. TEAM & INDEPENDENT participants also received pedometers, portion control tableware, diet/exercise logs, and iPoDs during the intervention (the control arm received iPoDs upon completion of the study). In addition to monitoring accrual, retention and adverse events, effect sizes (variation) regarding changes in weight status and lifestyle behaviors were assessed at baseline, 6‐and 12‐month follow‐up. Survey data (e.g., dietary intake of energy, saturated fat, fruits and vegetables and nutrient density via 2‐day dietary recalls, level of physical activity via the Godin Leisure Time Physical Activity Questionnaire [with supporting accelerometry], social support, in general and specific to changing diet and exercise via the Duke Social Support Index and the Sallis et al. Social Support Index for Diet and Exercise, Stage of Readiness and Self‐Efficacy for diet and exercise change, perceived risk of recurrence [for mothers] and primary risk of breast cancer [for daughters], health‐related quality of life via the SF‐36, and strength of the mother‐daughter bond via the Interpersonal Closeness Score) were captured at each time point via computer‐assisted telephone interviews, and anthropometric measures (weight, height, waist circumference and blood pressure) were assessed inperson by study staff. Results: While this study is still in the field, at present the full sample has been accrued and randomized; characteristics of the study sample are as follows: Race/Ethnicity (73%White, 18%African American, 7% Hispanic and 2% Asian); Mean Years of Age (Mothers: 61/Daughters: 36), and Mean Distance Separating Dyad Members: 75 miles). It is noteworthy that although this study was able to achieve its accrual target, a substantial number of breast cancer cases (N=2336) were contacted in order fulfill enrollment. While only a 26% response rate was achieved for the initial screener which accompanied the letter of invitation, the leading reasons for women reporting that they could not participate was because they either did not have an adult‐aged daughter, or did not have a daughter who was overweight. At the time of this abstract submission, data collection is almost complete for the 6‐month time point. At this time, attrition is minimal (3%) and only two serious adverse events have been reported (none of which is attributable to the intervention). Preliminary findings from 57 dyads suggest that both the TEAM and INDEPENDENT interventions were associated with significant changes from baseline with decreases in mean dyadic weight (sd) over time being −6.44 (7.49) kg and −6.90 (8.91) kg, respectively as compared to the control −1.61 (6.0) kg (p‐values <.05). No significant differences were noted between the experimental interventions, though change scores were −3.2 vs. ‐3.0 kg (Mothers) and −2.9 vs. −3.5 kg (Daughters) for TEAM vs. INDEPENDENT interventions, respectively. BMI and waist circumference measurements mirror these findings. In addition, baseline to 6‐month increases in the level of moderate‐to‐vigorous physical activity were as follows: CONTROL: Mothers (29 min/week)/Daughters (19 min/week); TEAM: Mothers (53 min/week)/Daughters (55 min/week) and INDEPENDENT: Mothers (33 min/week)/Daughters (87 min/week)(overall p=.19/Team vs. Control p= .08 and Independent vs. Control p=.07). Conclusions: The mother‐daughter weight loss interventions appear feasible as indicated by full enrollment, excellent acceptance, low...

  • Abstract B4: A home-based intervention among older long-term cancer survivors improves physical activity, diet quality, weight status, and physical functioning: Results of the RENEW (Reach-out to ENhancE Wellness) trial

    by Miriam Morey, Denise Snyder, Richard Sloane, Bercedis Peterson, Harvey Cohen, Paige Miller, Terryl Hartman, Wendy Demark-Wahnefried

    B4 Cancer survival rates are ever increasing; currently two-thirds of cancer patients will be alive at least 5 years after diagnosis. Despite these gains, many cancer survivors are left with significant comorbidity and accelerated functional decline. Older survivors experience greater declines in function, threatening independence and resulting in increased health care costs. The aim of the RENEW trial was to determine if a year-long, diet-exercise intervention delivered to older long-term cancer survivors via telephone prompts, counseling, and mailed materials could effectively improve health behaviors, and result in improved weight status, and physical functioning. Cancer cases were ascertained from cancer registries and self-referral: 20,015 letters of invitation were posted, 1,208 survivors were screened [eligibility criteria: age 65+; breast, prostate or colorectal cancer diagnosed at least 5-years prior with no evidence of recurrence; body mass index (BMI-kg/m2) 25-40; Citation Information: Cancer Prev Res 2008;1(7 Suppl):B4.

  • Measurement of the total width, the electronic width, and the mass of theΥ(10580)resonance

    by B. Aubert, R. Barate, D. Boutigny, F. Couderc, A. Hicheur, Y. Karyotakis, J. P. Lees, V. Tisserand, A. Zghiche, A. Palano, et al.

    We present a measurement of the parameters of the Υ(10580) resonance based on a dataset collected with the BABAR detector at the SLAC PEP-II asymmetric B factory. We measure the total width Γtot=(20.7±1.6±2.5)  MeV, the electronic partial width Γee=(0.321±0.017±0.029)  keV and the mass M=(10579.3±0.4±1.2)  MeV/c2.


  • Improved Measurement ofCPAsymmetries inB0→(cc¯)K0(*)Decays

    by B. Aubert, R. Barate, D. Boutigny, F. Couderc, A. Hicheur, Y. Karyotakis, J. P. Lees, V. Tisserand, A. Zghiche, A. Palano, et al.

    We present results on time-dependent CP asymmetries in neutral B decays to several CP eigenstates. The measurements use a data sample of about 227×106 Υ(4S)→BB¯ decays collected by the BABAR detector at the PEP-II asymmetric-energy B Factory at SLAC. The amplitude of the CPasymmetry, sin2β in the standard model, is derived from decay-time distributions from events in which one neutral B meson is fully reconstructed in a final state containing a charmonium meson and the other B meson is determined to be either a B0 or B¯0 from its decay products. We measure sin2β=0.722±0.040(stat)±0.023(syst) in agreement with the standard model expectation.


  • Top Cited Papers

    Study of the B−→J/ψK−π+π− decay and measurement of the B−→X(3872)K− branching fraction

    by B. Aubert, R. Barate, D. Boutigny, F. Couderc, J.-M. Gaillard, A. Hicheur, Y. Karyotakis, J. P. Lees, V. Tisserand, A. Zghiche, et al.

    We study the decay B−→J/ψK−π+π− using 117×106 BB¯ events collected at the Y(4S) resonance with the BABAR detector at the PEP-II e+e− asymmetric-energy storage ring. We measure the branching fractions B (B−→J/ψK−π+π−)=(116±7(stat.)±9(syst.))×10−5 and B (B−→X(3872)K−)× B (X(3872)→J/ψπ+π−)=(1.28±0.41)×10−5 and find the mass of the X(3872) to be 3873.4±1.4  MeV/c2. We search for the hc narrow state in the decay B−→hcK−, hc→J/ψπ+π− and for the decay B−→J/ψD0π−, with D0→K−π+. We set the 90% C.L. limits B(B−→hcK−)×B(hc→J/ψπ+π−)<3.4×10−6 and B(B−→J/ψD0π−)<5.2×10−5.